MGX Buy Disclosure
Reid Laurence · SEC Form 4 · Filed Sep 11, 2026
Buy
Calculated transaction value
$138.06
Reid Laurence Director
MGX
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
MGX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 117 shares @ $1.18
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-389550
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$23.4K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. MGX Current | Buy | Sep 9, 2026 | $138.06 |
| Metagenomi Therapeutics, Inc. MGX | Buy | Sep 9, 2026 | $23.26K |